Roivant Sciences Stock Performance
| ROIV Stock | USD 28.28 -0.54 -1.87% |
Risk-Adjusted Performance
0High
6 · Contained
Roivant Sciences currently ranks below 6% of comparable global equities and portfolios when recent risk-adjusted returns are measured across a 90-day horizon. At large-cap scale, institutional coverage and secondary-market liquidity are typically well established. Roivant Sciences is showing early signs of positive return efficiency on a risk-adjusted basis. Learn More
Relative Risk vs. Return Landscape
If you had invested $ 2,582 in Roivant Sciences on February 6, 2026 and sold it today, you would have earned $ 246.00 , a return of 9.53% over 90 days. Roivant Sciences is currently generating a 0.1678% daily expected return and carries 2.18% risk (volatility on return distribution) over a 90-day horizon. In relative terms, Roivant Sciences exhibits above-average volatility, exceeding roughly 81% of comparable stocks, and ROIV has trailed 97% of traded instruments in return over the 90-day horizon. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
For Roivant Sciences Stock, the tendency of price to converge toward a long-term average provides a useful forecasting baseline. Investors have relied on this tendency for decades, though persistent mispricings in some instruments suggest additional risk factors. Certain stocks show persistent deviations from their intrinsic value estimates, typically explained by the risk investors bear. Applying mean reversion analysis to Roivant Sciences Stock helps identify potential entry points when prices are extended.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 28.28 | 90 days | 28.28 | about 42.51 % |
Based on standard probability analysis, the odds of Roivant Sciences moving above the current price in 90 days from now are about 42.51 %. Over this horizon, the return distribution for this stock has leaned toward above-current outcomes historically. (The curve highlights the price band where the market has recently concentrated expectations for Roivant Sciences Stock over the next 90 days). A narrower shape indicates the market has recently priced Roivant Sciences Stock into a more concentrated outcome range.
Roivant Sciences Price Density |
| Price |
Predictive Modules for Roivant Sciences
A variety of analytical techniques are available for forecasting Roivant Sciences and the broader stock market. From technical pattern analysis to statistical models, each method contributes a different perspective on Roivant Sciences. A systematic comparison of model outputs provides context to form a more balanced perspective on Roivant Sciences. Refining forecasting methods over time can incrementally improve the quality of decisions made about Roivant Sciences.The mean reversion principle applied to Roivant Sciences' suggests that neither prolonged outperformance nor underperformance is permanent. Identifying the root cause of Roivant Sciences' price dislocation is essential before acting on a mean reversion signal. The mean reversion tendency in Roivant Sciences' price is a well-documented phenomenon in academic research. In many cases, Roivant Sciences' price extremes present statistical patterns that have recurred historically.
Primary Risk Indicators
The past 10-20 years have brought considerable volatility to the stock market, with Roivant Sciences experiencing notable price swings. Roivant Sciences has reflected this volatile environment with periods of significant price swings. Tracking shifts in Roivant Sciences' fundamental risk indicators is one approach to mitigating this exposure. This risk data equips investors with the information needed to adjust Roivant Sciences exposure proactively.α | Alpha over Dow Jones | 0.15 | |
β | Beta against Dow Jones | 0.92 | |
σ | Overall volatility | 0.90 | |
Ir | Information ratio | 0.07 |
Investor Alerts and Insights
Alerts and suggestions for Roivant Sciences give investors a structured way to monitor the stock for material events. Roivant Sciences alerts cover shifts in fundamentals, technical conditions, and significant market-moving events. Alert frequency for Roivant Sciences adjusts dynamically based on market volatility and event activity. Regularly reviewing Roivant Sciences alerts keeps investors aligned with evolving market conditions.| Roivant Sciences has high likelihood to experience some financial distress in the next 2 years | |
| ROIV reported previous year's revenue of $29.05 million. Net Loss for the year was -$356.73 million with loss before overhead, payroll, taxes, and interest of -$614.67 million. | |
| Roivant Sciences currently holds about $1.94 billion in cash as of latest reporting with -$839.45 million of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76. | |
| Roughly 23.0% of ROIV outstanding shares are owned by corporate insiders |
Price Density Drivers
Price behavior in Roivant Sciences reflects the combined effect of buyer and seller positioning dynamics and market sentiment. Reviewing the indicators below provides context for understanding the current drivers of Roivant Sciences price. Price density analysis for Roivant Sciences focuses on the forces that drive short-term price movements. Use the table below as a reference for tracking Roivant Sciences's key price density drivers over time.
| Common Stock Shares Outstanding | 725.4 million | |
| Cash And Short Term Investments | 4.89 billion |
Roivant Sciences Fundamentals Growth
Roivant Sciences Stock performance is fundamentally tied to Roivant Sciences' financial health and growth outlook. Investors track revenue and earnings growth, margin stability, and balance sheet health for Roivant Sciences Stock. The market prices Roivant Sciences Stock according to Roivant Sciences' ability to generate revenue and manage debt effectively. Investors evaluating Roivant Sciences Stock should focus on Roivant Sciences' earnings quality and revenue momentum.
| Current Valuation | 15.88 B | |||
| Shares Outstanding | 715.7 M | |||
| Earnings Per Share | -1.17 X | |||
Performance Metrics & Calculation Methodology
Return quality for Roivant Sciences evaluates how consistent and repeatable performance has been across periods. Return persistence over multiple periods suggests a stable underlying driver rather than one-off outcomes. Roivant Sciences shows ROE of -19.14%, ROA of -14.47% (TTM).
Roivant Sciences values are built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Return and risk statistics are calculated from historical price series.
Editorial review and methodology oversight provided by: Michael Smolkin, Member of Macroaxis Board of Directors